Page last updated: 2024-09-04

n(6)-benzyl-cyclic adenosine 5'-monophosphate and tetradecanoylphorbol acetate

n(6)-benzyl-cyclic adenosine 5'-monophosphate has been researched along with tetradecanoylphorbol acetate in 1 studies

Compound Research Comparison

Studies
(n(6)-benzyl-cyclic adenosine 5'-monophosphate)
Trials
(n(6)-benzyl-cyclic adenosine 5'-monophosphate)
Recent Studies (post-2010)
(n(6)-benzyl-cyclic adenosine 5'-monophosphate)
Studies
(tetradecanoylphorbol acetate)
Trials
(tetradecanoylphorbol acetate)
Recent Studies (post-2010) (tetradecanoylphorbol acetate)
50131,050612,217

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beiske, K; Blomhoff, HK; Lømo, J; Smeland, EB; Stokke, T1

Other Studies

1 other study(ies) available for n(6)-benzyl-cyclic adenosine 5'-monophosphate and tetradecanoylphorbol acetate

ArticleYear
TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes.
    Journal of immunology (Baltimore, Md. : 1950), 1995, Feb-15, Volume: 154, Issue:4

    Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Apoptosis; B-Lymphocytes; Cells, Cultured; Colforsin; Cyclic AMP; DNA Damage; Humans; Lectins, C-Type; Lymphocyte Activation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Tetradecanoylphorbol Acetate; Thionucleotides; Transforming Growth Factor beta

1995